?-blocker improves survival, left ventricular function, and myocardial remodeling in hypertensive rats with diastolic heart failure

Background:Chronic -blocker therapy improves survival and left ventricular (LV) systolic function in patients with congestive heart failure. However, its efficacy in diastolic heart failure (DHF) with preserved normal LV systolic function remains uncertain.